Hannah E. Bowrey, PhD
a:1:{i:0;s:87:"Janssen Scientific Affairs, LLC, a company of Johnson & Johnson, Titusville, New Jersey";}
Original Research
Esketamine Nasal Spray vs Quetiapine ER in Treatment-Resistant Depression
January 27, 2025
Esketamine was associated with significantly larger improvements in work productivity loss and related costs compared to quetiapine, suggesting greater benefits from patient well-being and employer perspectives.
